Why the Companies That Actually Make Your Drugs Are in a Merger Frenzy
$
Why the Companies That Actually Make Your Drugs Are in a Merger Frenzy
May 15, 2017
FortuneSy Mukherjee
Biosimilars Are Coming After Big Pharma’s Bottom Line
$
Biosimilars Are Coming After Big Pharma’s Bottom Line
Jan 12, 2016
FortuneLaura Lorenzetti
Biogen Shares Are Spiking On Rumors of a Mega-Deal With Its Rivals
$
Biogen Shares Are Spiking On Rumors of a Mega-Deal With Its Rivals
Aug 2, 2016
FortuneSy Mukherjee
Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
$
Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
Jan 7, 2022
FortuneJeremy Kahn
Big Pharma Innovation in Small Places
$
Big Pharma Innovation in Small Places
May 13, 2016
FortuneJennifer Alsever
Scientists are analyzing samples in medical research laboratory. Scientific searching for vaccine with microscope to treat diseases in medicine. Pharmaceutical Lab and biotechnology development
0:15
$
Scientists are analyzing samples in medical research laboratory. Scientific searching for vaccine with microscope to treat diseases in medicine. Pharmaceutical Lab and biotechnology development
Feb 27, 2023
shutterstockCinematicVid
Why Did New Drug Approvals in the U.S. Plunge This Year?
$
Why Did New Drug Approvals in the U.S. Plunge This Year?
Dec 15, 2016
FortuneSy Mukherjee
$
The world is obsessed with new COVID drugs. But other important treatments are in the works, too
Sep 28, 2020
FortuneSy Mukherjee
$
The FDA Approved the First New Sickle Cell Drug in 20 Years…But It’s Not a Cure
Jul 10, 2017
FortuneSy Mukherjee
$
A Powerful New Antibiotic May Have Been Living in Our Noses This Whole Time
Jul 27, 2016
FortuneSy Mukherjee
$
Could a Molecular ‘On-Off Switch for Agony’ Lead to a Safer Painkiller?
Jul 7, 2016
FortuneDamian Garde,STAT News
$
Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
Oct 6, 2016
FortuneSy Mukherjee
$
Why Biotech’s Biggest Breakthrough Is Now In Dispute
Jan 20, 2016
FortuneLaura Lorenzetti
$
Bristol-Myers Is Buying Celgene for $74 Billion in One of the Largest Big Pharma Mergers Ever
Jan 3, 2019
FortuneBloomberg
7:26
$
Bristol-Myers Squibb CEO talks $13 billion acquisition of heart drugs developer MyoKardia
Oct 5, 2020
CNBC
$
Novartis
Oct 23, 2024
FortuneFortune Staff
$
Insurers are Rebelling Against the FDA’s Most Controversial 2016 Drug Approval
Dec 14, 2016
FortuneSy Mukherjee
See more
Static thumbnail place holder